Filing Details
- Accession Number:
- 0001213900-24-038573
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2024-05-01 17:02:03
- Reporting Period:
- 2024-04-17
- Accepted Time:
- 2024-05-01 17:02:03
- Original Submission Date:
- 2024-02-26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1563577 | Galera Therapeutics Inc. | GRTX | Pharmaceutical Preparations (2834) | 461454898 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2008233 | Yair Schneid | 1 Wood Lane Suffern NY 10901 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-04-17 | 318,150 | $0.19 | 8,361,353 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-17 | 100,000 | $0.19 | 8,461,353 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-17 | 68,424 | $0.20 | 8,529,777 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-17 | 241,028 | $0.20 | 8,770,805 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-17 | 56,900 | $0.21 | 8,827,705 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-17 | 50,000 | $0.21 | 8,877,705 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-17 | 50,000 | $0.21 | 8,927,705 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-17 | 243,100 | $0.22 | 9,170,805 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-17 | 551,217 | $0.23 | 9,722,022 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-17 | 453,988 | $0.24 | 10,176,010 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-18 | 17,211 | $0.19 | 10,193,221 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-18 | 100,000 | $0.19 | 10,293,221 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-18 | 100,000 | $0.20 | 10,393,221 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-18 | 247,600 | $0.20 | 10,640,821 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-18 | 4,245 | $0.20 | 10,645,066 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-18 | 4,342 | $0.20 | 10,649,408 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-18 | 74,202 | $0.20 | 10,723,610 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-19 | 100 | $0.19 | 10,723,710 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-19 | 314 | $0.19 | 10,724,024 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-19 | 215 | $0.19 | 10,724,239 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2024-04-19 | 99,371 | $0.19 | 10,823,610 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
